{"id":1201416,"title":"DSEN Abstract: Hepatitis C Virus Treatment: Contribution of Patient Genetics in Ribavirin-induced Anemia - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2026-03-18","captureTimestamp":"2026-03-18T07:27:37.223000+00:00","jobId":8,"originalUrl":"https://cihr-irsc.gc.ca/e/52727.html?wbdisable=false","snippet":"DSEN Abstract Hepatitis C Virus Treatment: Contribution of Patient Genetics in Ribavirin-induced Anemia In the treatment of chronic hepatitis C, ribavirin is often incorporated to improve treatment effectiveness. However, 1 in 3 treated patients develop severe anemia. This study…","rawSnapshotUrl":"/api/snapshots/raw/1201416","browseUrl":"https://replay.healtharchive.ca/job-8/20260318072737/https://cihr-irsc.gc.ca/e/52727.html?wbdisable=false#ha_snapshot=1201416","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}